<DOC>
	<DOCNO>NCT01626014</DOCNO>
	<brief_summary>Ovarian cancer account death gynecologic malignancy . The majority patient diagnosed Stage III-IV disease . Nearly 80 % patient recur result 5-year survival rate 14-32 % . Although enrollment increase hospice , hospice program challenge reach eligible patient . Several factor limit number people enroll hospice length hospice stay . Prognostication challenge increase availability cancer therapy people cancer set stage mismatch certification 6 month prognosis contemporary medical care . Additionally patient often aware hospice service provide .</brief_summary>
	<brief_title>Interactive Educational Website Women With Ovarian Cancer &amp; Caregivers</brief_title>
	<detailed_description>In study , pilot-test technology-based approach woman Stage III/IV recurrent ovarian cancer , caregiver , provider assist study decision-making process surround end-of-life decision , specifically , opt palliative care and/or entry hospice care . We randomize woman caregiver either intervention control websites . All subject complete battery demographic , psychosocial , health status outcome , health information , decision making measure baseline 60-day post-baseline . Once participant complete baseline survey , he/she automatically bring assign website . Both patient caregiver assign group ( intervention control ) . All participant open access respective study websites minimum 60 day . During enrollment , participant agree access respective website least 2-3 time per week . Both patient caregiver assign control arm view website contain document generally provide part usual care . They request log frequency intervention group .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<criteria>Women Stage III , IV recurrent ovarian , primary peritoneal fallopian tube cancer nominate caregiver woman 18 year old old At least 5th grade education Able read write English Access computer internet Voluntary write informed consent study entry , understanding consent may withdraw subject time without prejudice future medical care No known major psychiatric neurological diagnosis ( schizophrenia active chemical dependency ) Borderline ovarian cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Stage III ovarian cancer</keyword>
	<keyword>Stage IV ovarian cancer</keyword>
	<keyword>recurrent ovarian cancer</keyword>
	<keyword>primary peritoneal cancer</keyword>
	<keyword>fallopian tube cancer</keyword>
</DOC>